Global Cannabis Applications Corp

Investment Highlights

• Strong business drivers: – multi-billion-dollar market phenomenon, – total lack of trusted cannabis related information.
• Citizen Green solution to become most trusted source for “all things cannabis”.
• Patented and proprietary blockchain, mobile app and artificial intelligence intellectual property.
• Revenue and user growth achievable from numerous sources.
• Prescriptii and CannaLife apps launching 4Q2017 seeded with existing Fundametal app users.
• Proprietary specialized database IP “CannaCube” powered by + 10 years of medical cannabis patient data.
• Excellent capital structure. Strong leadership team committed to growth and shareholder value.

At Global Cannabis Applications, we are focused on becoming the most trusted source for all information relating to the medical cannabis community, by offering the best content, most trusted information and a most user/patient-friendly experience available. The medical cannabis market suffers from a noticeable lack of products and data. Our Citizen Green platform, an end-to-end infrastructure, uses six core technologies to aggregate anecdotal and clinical trial data to pre-qualify candidates for clinical studies, increasing the speed and efficiency of data collection and the approval process for medical cannabis products.

The Citizen Green platform begins with patients using mobile apps to capture experiences, artificial intelligence uses predictive analysis to turn anecdotal data into valued outputs, reg tech ensures regulatory compliance and the user registry database holds the data. Blockchain is the immutable trusted distributed ledger with digital tokens to award participants for sharing.

Opportunity

In the multibillion-dollar global medical cannabis markets, there is a noticeable lack of regulatory approved medical cannabis products beyond it’s basic leaf form. The regulatory process to approve cannabis products is slow and inefficient, and it takes substantial time to generate data for product approvals through clinical studies. With over forty two (42) governments globally moving forward with the legalization of medical cannabis, there is a need and an opportunity to fill the medical cannabis data void using advanced technology.

We present the GCAC’s Citizen Green Technology Platform. Our leading-edge data platform pre-qualifies candidates for clinical studies and adds to the streamlining of the approval process.

The Citizen Green platform is the world’s first end-to-end – from seed to sale to patient to regulator – medical cannabis data solution. It uses 6 core technologies: mobile applications, artificial intelligence, Reg Tech, smart databases, blockchain and digital reward tokens, all designed to speed the process of quality data and provide better qualified candidates for clinical studies.

As our community grows and the database builds, the platform gathers ‘deep learnings’ from all Data points and becomes more efficient with the prospect of delivering premium data to the industry, and prequalified applicants for clinical studies.

Our Technology Platform

Our Citizen Green Pain to Strain process is the world’s first truly user driven data model, helping create safer & better medical cannabis products.

Management

BRAD MOORE
CEO & Director

20 years of practical business leadership experience with Fortune 500 companies.

Strong background with internet-based start-up corporations.

Proven track record restructuring and developing early-stage businesses.

Holds an MBA from Royal Roads University.

ALEXANDER HELMEL
CFO & Director

12 years experience in the Canadian capital markets.

Over 20 years within the Information Technology sector.

Specializes in developing corporate growth strategies, building senior management teams, and developing corporate assets.

Intimate knowledge of internal control strategies and corporate governance guidelines.

BSc. (Mathematics), Certified Information Systems Auditor (CISA) 2006.

EYAL MARGALIT
CTO

Over 20 years of experience in building technology companies.

Two of the companies he founded and led accomplished significant exits.

Vast experience in all aspects of technology development management and the translation of tech to business.

Strong understanding of the medical cannabis space with a focus on R&D.

HANAN GELBENDORF
CMO

Over 20 years of global marketing experience, in an agency setting as well as in corporate America.

Vast experience and proven record of delivering results for early-stage businesses and established F500 companies.

Specializes in Leading all the aspects and processes of marketing.

Holds an MBA from the Smeal College of management at Penn State University.

JEFFREY HAYZLETT
Director

Chairman of C-Suite Network, home of the world’s most trusted network of C-Suite leaders, and a notable media personality.

CEO The Hayzlett Group.

TV & Radio host, Bloomberg Television & CBS Radio.

Global CMO at Eastman Kodak.

Additional Information

• Homepage
• White Paper
• Investor Deck